The pharmaceutical industry stands at a critical inflection point. After decades of optimising for cost efficiency and concentrating manufacturing in a handful of high-volume hubs, the sector is now confronting the stark reality that pharmaceutical API sourcing 2026 demands a fundamentally different approach. Geopolitical tensions, pandemic-induced disruptions, and regulatory pressures have exposed the fragility of single-source dependencies, forcing pharmaceutical companies to rethink their entire sourcing architecture.
For buyers navigating this transformed landscape, CPHI Milan's API zone—spanning Halls 2, 3, and 4—offers a strategic platform to connect with diversified, quality-assured suppliers capable of supporting resilient supply chains in an increasingly deglobalised world.


